Abstract:Objective:To investigate the role of IκB kinase (IKK)/nuclear factor-κB (NF-κB) signaling pathway in the development of Myc-induced mouse hepatocellular carcinoma and potential mechanisms.Methods:Transgenic mice were used in the study. LAP-tTA mice were crossed with Alb-cre transgenic mice, and the double transgenic offsprings were crossed to nuclear factor-κB essential modulator (NEMO f1) mice to generate LAP-tTA + /Alb-cre + /NEMO fl/wt mice, which lastly were crossed to tetO-Myc + mice. Four groups of animals were included: (1) WT mice (no expression of Myc and no NEMO ablation), (2) NEMO ΔLPC mice (specific deletion of NEMO in liver parenchymal cells but no expression of Myc), (3) Myc LAP-tTA mice (only overexpression of Myc, no ablation of NEMO), and (4) Myc LAP-tTA/NEMO ΔLPC mice (both overexpression of Myc and ablation of NEMO). Kaplan-Meier survival curve was recorded, and liver was observed both macroscopically and microscopically. Hematoxylin and eosin (HE) staining was used to observe the pathology of liver tissues. Immunohistochemical staining, Western blotting and quantitative polymerase chain reaction (qPCR) were performed to detect liver tumor markers and liver progenitor cell markers. Results:The Kaplan-Meier survival curve of mice showed that the median survival time of Myc LAP-tTA/NEMO ΔLPC mice was significantly shorter than that of Myc LAP-tTA mice, and the difference was statistically significant (Median survival time M/P 50, 56 d vs. 83 d, P<0.05). The serum levels of aspartate aminotransferase [(739.40±35.61) U/L vs. (441.50±78.79) U/L, t=2.464, P<0.05], alkaline phosphatase [(3 142.0±287.6) U/L vs. (1 702.0±278.8) U/L, t=3.129, P<0.01], γ-glutamin transferase [(101.70±12.82) U/L vs. (37.31±9.34) U/L, t=3.927, P<0.01] and total bilirubin [(1.281±0.232) mg/dl vs. (0.618±0.051) mg/dl, t=3.889, P<0.01] were significantly increased in livers of Myc LAP-tTA/NEMO ΔLPC mice compared to Myc LAP-tTA mice ( P<0.05); Western blotting analysis showed that cytokeratin 19 (CK19) and sex determining region Y box 9 (SOX9) protein levels in Myc LAP-tTA/NEMO ΔLPC mice were significantly higher than those in Myc LAP-tTA group. The mRNA levels of hepatic progenitor cell markers such as keratin (CK19, 4.336±1.970 vs. 0.680±0.234, t=1.843, P<0.01), CK7 (3.884±0.338 vs. 2.370±0.525, t=2.422, P<0.01), alpha fetal protein (AFP, 3 614.0±2 070.0 vs. 1 399.0±319.9, t=1.057, P<0.01) and epithelial cell adhesion molecule (EpCAM, 7.900±0.997 vs. 3.084±0.711, t=3.943, P<0.01) were significantly increased in Myc LAP-tTA/NEMO ΔLPC mice compared to Myc LAP-tTA group ( P<0.05). Conclusion:Inhibition of IKK/NF-κB signaling pathway could accelerate Myc-induced hepatocarcinogenesis and induce the development of hepatocellular-cholangiocarcinoma (HCC-ICC). Interleukin (IL)-6/signal transducer and activators of transcription 3 (STAT3) pathway and extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway maybe involved in the progression of mixed HCC-ICC.

Role of Myc in Hepatocellular Proliferation and Hepatocarcinogenesis.

Ire1 Alpha Rnase-Dependent Lipid Homeostasis Promotes Survival In Myc-Transformed Cancers

C-Myc-induced Chemosensitization is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-Kappa B Activity in Pancreatic Cancer Cells.

A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis.

A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis

Distinct Functions of Transforming Growth Factor-Β Signaling in C-Myc Driven Hepatocellular Carcinoma Initiation and Progression.

c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease

c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate

Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration

Effect of liver knockout of nuclear factor-κB essential modulator on the development of mouse hepatocarcinogenesis induced by Myc overexpression

Myc controls NK cell development, IL-15-driven expansion, and translational machinery

The mTORC2‐Akt1 Cascade Is Crucial for c‐Myc to Promote Hepatocarcinogenesis in Mice and Humans

Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis.

Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma

Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma

MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes

Mitochondrial fragmentation is crucial for <i>c</i>-<i>Myc</i>-driven hepatoblastoma-like liver tumors

Myc Suppresses Tumor Invasion and Cell Migration by Inhibiting JNK Signaling.

Myc inhibition tips the immune balance to promote antitumor immunity

Identification of MYC synthetic lethal genes and networks

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis